TR200002078T2 - Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar. - Google Patents
Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.Info
- Publication number
- TR200002078T2 TR200002078T2 TR2000/02078T TR200002078T TR200002078T2 TR 200002078 T2 TR200002078 T2 TR 200002078T2 TR 2000/02078 T TR2000/02078 T TR 2000/02078T TR 200002078 T TR200002078 T TR 200002078T TR 200002078 T2 TR200002078 T2 TR 200002078T2
- Authority
- TR
- Turkey
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- synthetic polysaccharides
- polysaccharides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
Abstract
Mevcut bulus asidik formdaki sentetik polisakkarid ve bunun farmasötik olarak kabul edilebilen tuzlari olup, bahsedilen polisakkaridin anyonik formu istem 1'de tanimlanan formül (I) ila (V)'ten birine karsilik gelmektedir. Bahsedilen polisakkaridler koagulasyon düzensizliklerine bagli hastaliklarin tedavisinde kullanilabilmektedir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9800515A FR2773804B1 (fr) | 1998-01-19 | 1998-01-19 | Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200002078T2 true TR200002078T2 (tr) | 2000-11-21 |
Family
ID=9521914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/02078T TR200002078T2 (tr) | 1998-01-19 | 1999-01-13 | Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar. |
Country Status (41)
Country | Link |
---|---|
US (1) | US6528497B1 (tr) |
EP (1) | EP1049721B1 (tr) |
JP (1) | JP4402835B2 (tr) |
KR (1) | KR100513196B1 (tr) |
CN (1) | CN1165550C (tr) |
AR (1) | AR013019A1 (tr) |
AT (1) | ATE209219T1 (tr) |
AU (1) | AU741748B2 (tr) |
BR (1) | BRPI9907025B8 (tr) |
CA (1) | CA2317465C (tr) |
CO (1) | CO4970795A1 (tr) |
CZ (1) | CZ297815B6 (tr) |
DE (1) | DE69900718T2 (tr) |
DK (1) | DK1049721T3 (tr) |
DZ (1) | DZ2709A1 (tr) |
EE (1) | EE04157B1 (tr) |
EG (1) | EG23982A (tr) |
ES (1) | ES2168000T3 (tr) |
FR (1) | FR2773804B1 (tr) |
GT (1) | GT199900003A (tr) |
HK (1) | HK1030002A1 (tr) |
HR (1) | HRP20000480B1 (tr) |
HU (1) | HU228333B1 (tr) |
IL (1) | IL137241A0 (tr) |
MA (1) | MA26597A1 (tr) |
MY (1) | MY119090A (tr) |
NO (1) | NO329903B1 (tr) |
NZ (1) | NZ505492A (tr) |
PE (1) | PE20000269A1 (tr) |
PL (1) | PL202802B1 (tr) |
PT (1) | PT1049721E (tr) |
RU (1) | RU2211224C2 (tr) |
SA (1) | SA99191113B1 (tr) |
SI (1) | SI1049721T1 (tr) |
SK (1) | SK283411B6 (tr) |
TR (1) | TR200002078T2 (tr) |
TW (1) | TW548279B (tr) |
UA (1) | UA60352C2 (tr) |
UY (1) | UY25356A1 (tr) |
WO (1) | WO1999036443A1 (tr) |
ZA (1) | ZA99355B (tr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2814463B1 (fr) * | 2000-09-22 | 2002-11-15 | Sanofi Synthelabo | Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
FR2874924B1 (fr) | 2004-09-09 | 2006-12-01 | Sanofi Aventis Sa | Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique |
TWI403334B (zh) | 2004-12-23 | 2013-08-01 | Merck Sharp & Dohme | 包含生物素殘基之抗血栓雙重抑制劑 |
GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
IL188647A0 (en) | 2008-01-08 | 2008-11-03 | Orina Gribova | Adaptable structured drug and supplements administration system (for oral and/or transdermal applications) |
WO2009130704A1 (en) * | 2008-04-24 | 2009-10-29 | Technion Research And Development Foundation Ltd. | Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds |
KR101529061B1 (ko) | 2008-05-30 | 2015-06-16 | 모멘타 파머슈티컬스 인코포레이티드 | 당류 구조물, 그리고 이러한 구조물의 제조 및 사용 방법 |
FR2935386B1 (fr) * | 2008-08-26 | 2010-09-10 | Sanofi Aventis | Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine |
WO2010117803A2 (en) * | 2009-03-30 | 2010-10-14 | University Of Georgia Research Foundation, Inc. | Heparan sulfate synthesis |
EP2451442A4 (en) | 2009-07-09 | 2014-02-12 | Oshadi Drug Administration Ltd | MATRIX COMPOSITION COMPOSITIONS, METHODS AND USES |
US8288515B2 (en) | 2009-07-31 | 2012-10-16 | Reliable Biopharmaceutical Corporation | Process for preparing Fondaparinux sodium and intermediates useful in the synthesis thereof |
FR2949114B1 (fr) | 2009-08-14 | 2011-08-26 | Sanofi Aventis | OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
FR2949115B1 (fr) | 2009-08-14 | 2012-11-02 | Sanofi Aventis | OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
US8420790B2 (en) | 2009-10-30 | 2013-04-16 | Reliable Biopharmaceutical Corporation | Efficient and scalable process for the manufacture of Fondaparinux sodium |
EP2614089A1 (fr) | 2010-09-10 | 2013-07-17 | Sanofi-Aventis | Polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree |
US9005664B2 (en) | 2010-10-17 | 2015-04-14 | Technion Research And Development Foundation Ltd. | Denatured lactoglobulin and polyphenol coassemblies |
FR2970969B1 (fr) | 2011-01-27 | 2013-10-18 | Sanofi Aventis | Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ260933A (en) * | 1993-07-16 | 1996-07-26 | Hercules Inc | Cation-complexed polysaccharides; use in foods and pharmaceuticals |
FR2749849B1 (fr) * | 1996-06-14 | 1998-09-04 | Sanofi Sa | Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant |
CZ427499A3 (cs) * | 1998-05-29 | 2000-05-17 | The Procter & Gamble Company | Jemné topické antimikrobiální přípravky |
-
1998
- 1998-01-19 FR FR9800515A patent/FR2773804B1/fr not_active Expired - Lifetime
-
1999
- 1999-01-13 JP JP2000540158A patent/JP4402835B2/ja not_active Expired - Fee Related
- 1999-01-13 KR KR10-2000-7007824A patent/KR100513196B1/ko not_active IP Right Cessation
- 1999-01-13 AU AU19745/99A patent/AU741748B2/en not_active Ceased
- 1999-01-13 BR BRPI9907025A patent/BRPI9907025B8/pt not_active IP Right Cessation
- 1999-01-13 CA CA002317465A patent/CA2317465C/en not_active Expired - Fee Related
- 1999-01-13 EP EP99900524A patent/EP1049721B1/fr not_active Expired - Lifetime
- 1999-01-13 IL IL13724199A patent/IL137241A0/xx not_active IP Right Cessation
- 1999-01-13 RU RU2000119753/04A patent/RU2211224C2/ru not_active IP Right Cessation
- 1999-01-13 DE DE69900718T patent/DE69900718T2/de not_active Expired - Lifetime
- 1999-01-13 NZ NZ505492A patent/NZ505492A/en not_active IP Right Cessation
- 1999-01-13 SI SI9930025T patent/SI1049721T1/xx unknown
- 1999-01-13 DK DK99900524T patent/DK1049721T3/da active
- 1999-01-13 WO PCT/FR1999/000044 patent/WO1999036443A1/fr active IP Right Grant
- 1999-01-13 PT PT99900524T patent/PT1049721E/pt unknown
- 1999-01-13 CN CNB998022438A patent/CN1165550C/zh not_active Expired - Fee Related
- 1999-01-13 UA UA2000074011A patent/UA60352C2/uk unknown
- 1999-01-13 HU HU0102009A patent/HU228333B1/hu not_active IP Right Cessation
- 1999-01-13 ES ES99900524T patent/ES2168000T3/es not_active Expired - Lifetime
- 1999-01-13 AT AT99900524T patent/ATE209219T1/de active
- 1999-01-13 CZ CZ20002635A patent/CZ297815B6/cs not_active IP Right Cessation
- 1999-01-13 SK SK1078-2000A patent/SK283411B6/sk not_active IP Right Cessation
- 1999-01-13 EE EEP200000429A patent/EE04157B1/xx unknown
- 1999-01-13 TR TR2000/02078T patent/TR200002078T2/tr unknown
- 1999-01-13 US US09/600,506 patent/US6528497B1/en not_active Expired - Lifetime
- 1999-01-13 PL PL341875A patent/PL202802B1/pl unknown
- 1999-01-14 GT GT199900003A patent/GT199900003A/es unknown
- 1999-01-15 MA MA25431A patent/MA26597A1/fr unknown
- 1999-01-16 EG EG5499A patent/EG23982A/xx active
- 1999-01-16 DZ DZ990010A patent/DZ2709A1/xx active
- 1999-01-18 UY UY25356A patent/UY25356A1/es not_active Application Discontinuation
- 1999-01-18 MY MYPI99000203A patent/MY119090A/en unknown
- 1999-01-18 AR ARP990100172A patent/AR013019A1/es active IP Right Grant
- 1999-01-18 TW TW088100716A patent/TW548279B/zh not_active IP Right Cessation
- 1999-01-19 PE PE1999000044A patent/PE20000269A1/es not_active Application Discontinuation
- 1999-01-19 CO CO99002526A patent/CO4970795A1/es unknown
- 1999-01-19 ZA ZA9900355A patent/ZA99355B/xx unknown
- 1999-02-27 SA SA99191113A patent/SA99191113B1/ar unknown
-
2000
- 2000-07-17 NO NO20003662A patent/NO329903B1/no not_active IP Right Cessation
- 2000-07-19 HR HR970630A patent/HRP20000480B1/xx not_active IP Right Cessation
-
2001
- 2001-02-12 HK HK01101003A patent/HK1030002A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200002078T2 (tr) | Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar. | |
ES2163530T3 (es) | Aplicacion de superoxido dismutasa (sod) en liposomas. | |
ES8500738A1 (es) | Un procedimiento para la preparacion de una composicion antiinflamatoria topica como unguento en forma de gel | |
BR9813811A (pt) | "composições farmacêuticas compreendendo micelas que compreendem glicocorticosteróide lipofìlico e apenas um único tensoativo" | |
FR2562539B1 (fr) | Nouveaux derives de l'acide vinyl-4 benzoique, leur procede de preparation et leurs applications en therapeutique et comme ligands | |
HUP9903906A2 (hu) | Kelátképző clioquinol felhasználása Alzheimer-kór kezelésére alkalmas gyógyszerkészítmények előállításánál | |
RO116342B1 (ro) | Compoziţie farmaceutică lichidă, orală | |
BG101118A (en) | Therapeutical compounds | |
BR9809117A (pt) | Composição de gel retardado de liberação prolongada, processo de produzir a mesma, formulação farmacêutica,e , processos de tratamento de uma indicação , de uma doença, e de uma inflamação com uma composição de liberação prolongada | |
BR0109672A (pt) | Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente | |
RU92016463A (ru) | Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе | |
DE69914084D1 (de) | Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen | |
ES2173858T3 (es) | Analogos de huperzina a. | |
HUP9602498A2 (hu) | Antimikrobiális hatású gyógyászati készítmények | |
PT96400A (pt) | Processo de preparacao de composicoes farmaceuticas a base de complexos de acido quinolona-carboxilico-iao metalico-acido | |
FI940696A (fi) | Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö | |
DE69713300T2 (de) | Benzopyran derivate mit leukotrien-antagonistischer wirkung | |
ATE172117T1 (de) | Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten | |
MD522G2 (ro) | Noi derivaţi de piperidinii tioindol, procedeu de preparare a lor, compoziţii farmaceutice care le conţin, utilizare a lor ca analgezice | |
HUP9902135A2 (hu) | (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására | |
GEP20032968B (en) | Use of Ketolides in Pharmaceutical Compositions for Preventing Thrombotic Arterial Complications Linked to Atherosclerosis | |
HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
ATE275953T1 (de) | 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis | |
TR200003451T2 (tr) | Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları | |
YU107692A (sh) | Sulfonamidi i postupak za njihovo dobijanje |